Press Releases Year None2020201920182017 Atreca, Inc. Announces Pricing of Underwritten Public Offering of Common Stock July 16, 2020 PDF Version READ MORE Atreca, Inc. Announces Proposed Underwritten Public Offering of Class A Common Stock July 15, 2020 PDF Version READ MORE Atreca and Xencor Enter Strategic Collaboration to Discover, Develop and Commercialize Novel T Cell Engaging Bispecific Antibodies July 8, 2020 PDF Version READ MORE Atreca Announces Webinar to Present ATRC-101 Preclinical Data Update on Monday, June 15, 2020 June 11, 2020 PDF Version READ MORE Atreca Announces Appointment of Kristine M. Ball to its Board of Directors May 21, 2020 PDF Version READ MORE Atreca Reports First Quarter 2020 Financial Results and Recent Corporate Developments May 14, 2020 PDF Version READ MORE Atreca Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program May 13, 2020 PDF Version READ MORE Atreca Announces Participation in the 2020 RBC Capital Markets Virtual Global Healthcare Conference May 12, 2020 PDF Version READ MORE Atreca, BeiGene, and IGM Biosciences Agree to Collaborate on Novel Antibody Treatment for COVID-19 April 29, 2020 PDF Version READ MORE Atreca Announces Participation in Two Upcoming Virtual Investor Conferences April 6, 2020 PDF Version READ MORE Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 14
